Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioNTech SE
With
Pfizer
The study is designed to evaluate if the COVID-19 vaccine reduces COVID-19 disease as compared to placebo given to healthy adults 50 to 64 years of age. Approximately 25,500 participants will be randomly chosen to get either one dose of COVID-19 vaccine or of a placebo.
Age
50–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
People who are between 50 and 64 years old at their first appointment.
People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study.
You may not be if
People who had COVID-19 in the past 3 months (90 days) before their first visit.
People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.
